Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IQV
BuyIQVIA Holdings Inc. · Healthcare · United States · $43.1B · Avg Vol: $374M/d
COMPANY DESCRIPTION
IQVIA Holdings Inc. is a global leader providing advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its competitive moat stems from an unparalleled proprietary data estate combined with sophisticated analytics and clinical expertise, crucial for drug development and commercialization. The company is a key strategic partner for pharmaceutical and biotech firms worldwide.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.4B | 15.0B | 15.4B | 16.3B | 4.2% | 17.0B | 17.4B | 18.5B | 6.4% |
| EPS | 5.82 | 7.39 | 7.57 | 7.91 | 10.8% | 8.04 | 8.60 | 9.60 | 10.1% |
| Shares | 185.7M | 181.5M | 176.1M | 169.6M | -8.7% | 164.6M | — | — | — |
| Debt | 13.0B | 13.9B | 14.2B | 15.9B | 7.0% | 16.3B | — | — | — |
| Equity | 5.8B | 6.1B | 6.1B | 6.5B | 4.1% | — | — | — | — |
| Op CF | 2.3B | 2.1B | 2.7B | 2.7B | 5.5% | 2.8B | — | — | — |
| Inv CF | -2.0B | -1.6B | -1.4B | -2.3B | — | — | — | — | — |
| Fin CF | -329.0M | -382.0M | -878.0M | -150.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IQV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IQV | IQVIA Holdings Inc.(you) | $43.1B | 78 | Buy |
| IDXX.MX | IDEXX Laboratories, Inc. | $43.9B | 73 | Buy |
| A | Agilent Technologies, Inc. | $43.4B | 73 | Buy |
| ILMN | Illumina, Inc. | $32.6B | 78 | Buy |
| WAT | Waters Corporation | $40.7B | 63 | Hold |
| DGX | Quest Diagnostics Incorporated | $26.8B | 85 | Strong Buy |
| LH | Labcorp Holdings Inc. | $27.2B | 86 | Strong Buy |
| NTRA | Natera, Inc. | $47.0B | 56 | Hold |
| MEDP | Medpace Holdings, Inc. | $16.8B | 84 | Strong Buy |
| DHER34.SA | Danaher Corporation | $151.9B | 76 | Buy |
Peer medians: ROE -25.0% · P/E 30.3x · Gross margin 58.8%